@article{f882f49694a94047af26e7ec5f41935d,
title = "Genetic evidence for a link between favorable adiposity and lower risk of type 2 diabetes, hypertension, and heart disease",
author = "Hanieh Yaghootkar and Lotta, \{Luca A.\} and Jessica Tyrrell and Smit, \{Roelof A.J.\} and Jones, \{Sam E.\} and Louise Donnelly and Robin Beaumont and Archie Campbell and Tuke, \{Marcus A.\} and Caroline Hayward and Ruth, \{Katherine S.\} and Sandosh Padmanabhan and Jukema, \{J. Wouter\} and Palmer, \{Colin C.\} and Andrew Hattersley and Freathy, \{Rachel M.\} and Claudia Langenberg and Wareham, \{Nicholas J.\} and Wood, \{Andrew R.\} and Anna Murray and Weedon, \{Michael N.\} and Naveed Sattar and Ewan Pearson and Scott, \{Robert A.\} and Frayling, \{Timothy M.\}",
note = "Funding Information: H.Y., A.R.W., and T.M.F. are supported by the European Research Council grants 323195 and SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC. J.T. is funded by a Diabetes Research \& Wellness Foundation fellowship. S.E.J. is funded by the Medical Research Council (MR/M005070/1). R.B. is also funded by the Wellcome Trust and Royal Society grant 104150/Z/14/Z. M.A.T., A.M., and M.N.W. are supported by the Wellcome Trust Institutional Strategic Support Fund (WT097835MF). A.H. is a Wellcome Trust Senior Investigator and a National Institute of Health Research senior investigator. R.M.F. is a Sir Henry Dale Fellow (Wellcome Trust and Royal Society grant 104150/Z/14/Z). E.P. holds a Wellcome Trust New Investigator Award (102820/Z/13/Z). The Wellcome Trust provides support for GoDARTS (awards 072960/z/03/z and 099177/z12/z). The PROSPER study was supported by an investigator-initiated grant obtained from Bristol-Myers Squibb. J.W.J. is an Established Clinical Investigator of the Netherlands Heart Foundation (2001 D 032). Support for genotyping was provided by the 7th Framework Programme of the European Commission (223004) and by the Netherlands Genomics Initiative (Netherlands Consortium for Healthy Ageing grant 050-060-810). This work was performed as part of an ongoing collaboration of the PROSPER study group in the Universities of Leiden, Glasgow, and Cork. The research leading to these results has received funding from the Netherlands Consortium for Healthy Ageing and the European Commission Seventh Framework Programme (FP7/2007-2013) under grant agreement no HEALTH-F2-2009-223004 PHASE. The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336. GS:SFHS received core funding from the Chief Scientist Office of the Scottish Government Health Directorate CZD/16/6 and the Scottish Funding Council grant HR03006. Genotyping of the GS:SFHS samples was carried out by the Genetics Core Laboratory at the Wellcome Trust Clinical Research Facility, Edinburgh, Scotland, and was funded by the U.K.'s Medical Research Council and the Wellcome Trust. Ethics approval for the study was given by the National Health Service Tayside Research Ethics Committee (reference 05/S1401/89). EPIC-Norfolk was funded by the Medical Research Council Canada grants MC-UU-12015/1 and MC-PC-13048. Publisher Copyright: {\textcopyright} 2016 by the American Diabetes Association.",
year = "2016",
month = aug,
day = "1",
doi = "10.2337/db15-1671",
language = "English",
volume = "65",
pages = "2448--2460",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "8",
}